| Study Period | 2019 - 2032 |
| 2024 Market Size | USD 6.3 Billion |
| 2025 Market Size | USD 6.7 Billion |
| 2032 Forecast | USD 11.2 Billion |
| Growth Rate (CAGR) | 7.6% |
| Largest Country | U.S. |
| Fastest Growing Country | U.S. |
| Nature of the Market | Fragmented |
| Largest Application Category | Diabetes |
|
Explore the market potential with our data-driven report
The North American ambulatory infusion pumps market is valued at USD 6.3 billion in 2024, and the market size is predicted to reach USD 11.2 billion by 2030, advancing at a CAGR of 7.6% during 2025–2030. The market is driven by the surging prevalence of chronic diseases, rising geriatric population, increasing diabetic population, and growing demand for ambulatory services.
The market is also growing due to the rising prevalence of diabetes, obesity, and other chronic and lifestyle-associated conditions among the elderly in the U.S. Furthermore, the rise in the volume of surgical procedures and chemotherapy treatments is expected to drive the market in the coming years.
The regional market is also growing due to the rising awareness of diabetes management and increasing healthcare spending. Obesity and insulin resistance have been considered independent risk factors for diabetes; thus, the rising obese population is driving the demand for insulin delivery devices, thereby propelling the ambulatory infusion pumps market in the region.
Moreover, the trend of home infusion therapies is growing with the strengthening emphasis on the cost-effectiveness of healthcare. Thus, there is a continuous shift of patients from expensive sites, including emergency and other hospital departments, to less-costly alternative sites, such as clinics/centers and homes. An average home infusion costs around USD 230, while hospital-based infusions cost USD 590 per patient per infusion. This equals an average saving of around USD 360 per patient per infusion. Additionally, such alternative sites and home-based care offer greater convenience. Hence, due to the rising availability of advanced, cost-effective ambulatory infusion pumps, home infusion therapy is rapidly gaining acceptance among North American patients.
Accessories & consumables hold the larger share of around 60%, and this category will also witness the higher CAGR during the forecast period. This is primarily due to their repetitive purchases and availability of a broad range of accessories & consumables across the region. Further, the growing trend of single-use and disposable consumables, especially since the pandemic, continues to drive this category.
The product types analyzed in the report are listed below:
The intravenous category is the largest, with around 75% market share in 2024, and it will also be the fastest growing during the forecast period. IV infusion pumps are used to administer medications and fluids directly into the veins of patients, which enables rapid effect. These devices also allow for better dosage and rate of infusion control and offer compatibility with a wider range of medicines. They are used in people of all ages who are sick, injured, dehydrated from exercise or heat, or undergoing surgery.
We have studied these routes of administration:
Diabetes accounts for the largest revenue share, of 25%, in the North American ambulatory infusion pumps market in 2024. This can be attributed to the growing prevalence of diabetes and its complications in the region. Over 96 million people aged 18 years or older have prediabetes, which is 38.0% of the adult U.S. population. As it delivers doses of insulin at specific times, an infusion pump replaces the need for multiple daily injections with a continuous insulin infusion. Furthermore, the innovations in wearable diabetes management devices and their extended infusion periods are responsible for their rising adoption.
Oncology is the fastest-growing category in the market, primarily due to the rising incidence of cancer in the continent. As per the American Cancer Society, for the first time in recorded history, over 2 million new cancer diagnoses and 611,000 resulting deaths are expected in the U.S. in 2024. Infusion pumps are used for the delivery of chemotherapy agents, a number of which must be delivered at a constant rate and controlled amount. Cancer also causes significant pain, which is why infusion pumps are deployed for patient-controlled analgesia in hospital, long-term care, and homecare settings.
The report offers insights in the following applications:
The direct category dominates the market, and it will also witness the higher CAGR, of around 75%, during this decade. This can be mainly due to the fact that this channel is preferred by individual consumers, who are increasingly buying infusion pumps for home-based care. Moreover, the increasing utilization of e-prescriptions in the hospitals in the region is expected to support the market growth in this category during the forecast period. Moreover, the majority of the healthcare service providers in the continent, including hospitals, clinics, long-term-care centers, and hospice care centers, buy directly from the manufacturers, often in bulk, under long-term supply agreements.
These distribution channels are part of the research scope:
Drive strategic growth with comprehensive market analysis
The U.S. holds the larger share, of around 90%, in 2024, because of the presence of major players, developed healthcare infrastructure, favorable reimbursement policies, and surging prevalence of chronic diseases. In addition to this, the development of alternative healthcare settings and penetration of different home infusion services are contributing to the growth of the market. Furthermore, the presence of a large number of hospitals in the U.S. is expected to continue driving the regional market growth. According to the American Hospital Association (AHA), a total of 6,093 hospitals were operational in the U.S. in 2021, and, in 2024, the number has risen to 6,120. Moreover, the U.S. is home to 334.9 million people, while Canada is home to merely 40.1 million. This large difference means that the U.S. will continue to have the larger geriatric population and pool of patients with numerous acute and chronic diseases throughout this decade and beyond.
Here are the countries covered in the report:
The market is fragmented as there are both large multinational corporations and small, niche companies serving patient needs. While some companies offer comprehensive portfolios, the specialized ones generally focus on specific applications, such as chemotherapy or pain management. The pumps might even need to be customized as per the application, furthering the scope for new companies and intensifying the competition. Moreover, the increasing ‘connectedness’ of the healthcare system is impelling players to bring innovative features in their offerings, such as remote patient data sharing and EHR integration. The players also use diverse distribution channels; while to hospitals, they generally sell directly, to individuals, they market through specialty medical device stores and even online.
Want a report tailored exactly to your business need?
Request CustomizationLeading companies across industries trust us to deliver data-driven insights and innovative solutions for their most critical decisions. From data-driven strategies to actionable insights, we empower the decision-makers who shape industries and define the future. From Fortune 500 companies to innovative startups, we are proud to partner with organisations that drive progress in their industries.
Working with P&S Intelligence and their team was an absolute pleasure – their awareness of timelines and commitment to value greatly contributed to our project's success. Eagerly anticipating future collaborations.
McKinsey & Company
India
Our insights into the minutest levels of the markets, including the latest trends and competitive landscape, give you all the answers you need to take your business to new heights
We take a cautious approach to protecting your personal and confidential information. Trust is the strongest bond that connects us and our clients, and trust we build by complying with all international and domestic data protection and privacy laws
Customize the Report to Align with Your Business Objectives
Request the Free Sample Pages